---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-23-000040"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T06:16:09.936966+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Labcorp appoints Dr. Paul Rothman to Board of Directors

## Summary
- Dr. Rothman appointed as independent director effective June 6, 2023, expanding board to 12 members (11 independent).
- Rothman recently retired as CEO of Johns Hopkins Medicine, a $9B academic medical enterprise, after a decade of service.
- He is a rheumatologist and molecular immunologist with leadership roles at Columbia University and University of Iowa.
- Rothman currently serves on the boards of Merck & Co. and King Faisal Specialist Hospital and Research Center.
- Compensation follows Labcorp's standard director compensation program as described in the March 2023 proxy statement.

## SEC filing metadata
- accession: 0000920148-23-000040
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014823000040/0000920148-23-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014823000040/lh-20230605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-23-000040
- JSON: https://secwatch.observer/filing/0000920148-23-000040.json
- Plain text: https://secwatch.observer/filing/0000920148-23-000040.txt

## Key facts
- Executive change
  Paul B. Rothman was appointed as member of the Board at LABCORP HOLDINGS INC..
  - Action: appointed
  - Role: member of the Board
  source text: Laboratory Corporation of America Holdings (“Labcorp”) today announced that on June 5, 2023, Labcorp’s Board of Directors (the “Board”) appointed Paul B. Rothman as a member of the Board, effective June 6, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/920148/000092014823000040/0000920148-23-000040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.